Wednesday, July 8, 2026

pharma · Hepatocellular Carcinoma · Hepatocellular Carcinoma (HCC) · TPST

Tempest Therapeutics

News and analysis for Tempest Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Brisbane, USA HQ
14 Employees
Public company Type
TPST · NYSE Ticker
Company details
Status
Public
HQ
Brisbane, USA
Employees
14
Programs
3
Drugs
1
Patents
10
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Tempest Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Tempest Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Tempest Therapeutics yet.

Back to company overview →